Injective: Mixed momentum and overbought signals drive 7.07% rise

Traders Union
All News
Crypto
Injective jumps 7.07% to $3.33 today

Highlights

Injective holds above crucial support as investor attention centers on testing resistance at $3.02 and $3.13 for short-term recovery.
Market participants view the recent price reset as a technical pullback, not a deterioration in Injective's project fundamentals.
Despite a strong session near highs, technicals indicate mixed momentum and a likely sideways or lower price range of $3.00 to $3.60 over the next week.

Market reset narrative steadies sentiment amid consolidation at support

Recent developments focus on Injective consolidating above key support levels, with attention on resistance at $3.02 and $3.13. Technical analysis indicates that the prior price decline is viewed as a typical market reset, rather than reflecting a loss of project momentum. Coverage from March 9, 2026, highlights steady attention to short-term recovery targets for Injective.

Overbought signals clash with negative momentum as volatility rises

The D1 Ichimoku Kijun is at $3.40, serving as immediate resistance. Momentum signals are mixed: the D1 MACD indicates strong selling while ADX (15.86) reflects a weak overall trend. D1 RSI is neutral to slightly bearish at 48.26, Stoch RSI is overbought, and CCI sits near neutral. BBP shows buyers have a modest upper hand on intraday moves. The price opened with no real gap ($3.12 from a previous close of $3.11), and accelerated to near the session high ($3.32 in today’s range of $3.09 – $3.32), suggesting moderate volatility and a clear tone of strength toward session highs. However, the divergence between overbought oscillators and negative momentum signals caution, indicating persistent seller presence despite today’s strong upward move.

Sideways consolidation likely as sell signals limit upside probability

Looking ahead, the expected trading range for the next five sessions is $3.00 to $3.60, reflecting typical volatility against current levels. There is a very low probability (less than 20%) of a sustained price increase, as persistent sell signals remain evident from W1 RSI, ADX, MACD, and MA-50. The baseline scenario suggests price consolidation sideways within this band. A bullish break would require a move above $3.40, while downside risk could emerge if INJ drops below $3.00.

Anton Kharitonov, expert at Traders Union, sees a fragile technical recovery for Injective. He believes persistent negative momentum and seller presence limit any short-term upside, even as recent price action pushes toward resistance. Caution is warranted given weak trend signals and overbought oscillators. "Until INJ confidently reclaims $3.40, I remain defensive and do not trust any rally attempts."

Earlier, analysts noted that Injective faced persistent selling pressure and a lack of decisive bullish momentum, with technical readings skewed toward continued weakness. The latest market action confirms ongoing caution, reinforcing the importance of monitoring the $3.00 support zone as a potential turning point for near-term direction within the current consolidation range.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.